Table 2.
Perfusion-CT data, baseline and post-TACE.
| Mean | SD | Minimum | Maximum | |||
|---|---|---|---|---|---|---|
| Liver parenchyma (n = 52) | ALP | 13.4 | 6.8 | 3.0 | 30.9 | mL/100 mL/min |
| PVP | 60.3 | 25.2 | 23.3 | 137.6 | mL/100 mL/min | |
| HPI | 25.2 | 16.1 | 4.4 | 61.8 | % | |
| Liver parenchyma | ALP | 16.3 | 10.1 | 1.9 | 48.9 | mL/100 mL/min |
| post-TACE (n = 52) | PVP | 62.3 | 26.6 | 16.9 | 112.6 | mL/100 mL/min |
| HPI | 27.1 | 19.8 | 2.7 | 65.1 | % | |
| Liver parenchyma | ALP | 9.0 | 12.4 | 0.9 | 38.4 | mL/100 mL/min |
| follow-up (n = 23) | PVP | 62.5 | 26.7 | 22.5 | 129.5 | mL/100 mL/min |
| HPI | 25.4 | 25.0 | 1.4 | 73.1 | % | |
| HCC pre-TACE (n = 52) | ALP | 44.7 | 15.0 | 14.3 | 101.6 | mL/100 mL/min |
| PVP | 12.3 | 16.3 | 0.0 | 72.3 | mL/100 mL/min | |
| HPI | 85.8 | 16.6 | 18.2 | 100 | % | |
| HCC post-TACE, | ALP | 4.4 | 5.3 | 0.0 | 21.5 | mL/100 mL/min |
| responder (n = 42) | PVP | 32.0 | 27.7 | 1.4 | 102.0 | mL/100 mL/min |
| HPI | 30.4 | 26.8 | 0.0 | 83.4 | % | |
| HCC post-TACE, | ALP | 34.7 | 10.1 | 20.6 | 43.2 | mL/100 mL/min |
| non-responder (n = 10) | PVP | 18.8 | 14.1 | 4.1 | 40.6 | mL/100 mL/min |
| HPI | 67.7 | 21.4 | 39.8 | 93.4 | % | |
| Post-TACE rim region, | ALP | 8.8 | 8.7 | 0.8 | 37.5 | mL/100 mL/min |
| responder (n = 42) | PVP | 49.2 | 42.4 | 4.0 | 186.3 | mL/100 mL/min |
| HPI | 31.1 | 26.5 | 0.8 | 89.0 | % | |
| Post-TACE rim region, | ALP | 23.4 | 8.6 | 12.3 | 33.2 | mL/100 mL/min |
| non-responder (n = 10) | PVP | 53.2 | 16.9 | 34.5 | 70.9 | mL/100 mL/min |
| HPI | 33.0 | 7.0 | 27.0 | 42.6 | % |
SD = standard deviation, ALP = arterial-liver perfusion, PVP = portal-venous perfusion, HPI = hepatic-perfusion index.